About Granvalor
Granvalor is a Healthcare company. Speciality in dermatology and cosmeceutical products in India. It operates in the Healthcare and Consumer sectors. The company has 4 employees. Its Indian entity Granvalor Pharmaceuticals Private Limited reported revenue of ₹2.14 Cr. Granvalor offers products and services including Anti-Pigmentation Products and Anti-Ageing Products. Its focus areas include Pharmaceuticals, Dermatology, Skin Care Products and Cosmeceuticals.
Company details
Granvalor is recognized as a promising speciality dermatology and cosmeceutical company in India, where innovative therapeutic solutions are introduced for cosmetic and clinical dermatology. A commitment is made by the company to provide efficient and reliable products that emphasize high quality and safety profiles. Expertise in skin care is leveraged to develop unique formulations addressing diverse needs of the Indian market, including anti-pigmentation, anti-ageing, hair care, and anti-acne treatments, all while ensuring products meet rigorous standards for efficacy and reliability.
- Employees 4
- SectorsHealthcareConsumer
- Email••••••••
- Phone•••• ••••
- Legal Name Granvalor Pharmaceuticals Pvt. Ltd
- Date of Incorporation 25 Mar, 2011
- Jurisdiction Hyderabad, Telangana, India
- Indian entity revenue₹2.14 Cr
FY 2025 · +22% YoY
- Indian entity net profit₹6.7 Lakh
FY 2025 · 3% margin
- Indian entity EBITDA₹10.6 Lakh
FY 2025 · 5% margin
- Employee Count4
Associated legal entities of Granvalor
Granvalor operates through Granvalor Pharmaceuticals Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Granvalor Pharmaceuticals Private Limited CIN U24232TG2011PTC073508 | Active | 25 Mar 2011 | Hyderabad, Telangana | ₹2.1 Cr | 4 | 2 | View details |
Products & Services of Granvalor
Granvalor offers a comprehensive portfolio of products and services, including Anti-Pigmentation Products and Anti-Ageing Products.
Anti-pigmentation products are developed by Granvalor to treat localized increases in skin pigmentation through targeted ingredients like glutathione and kojic acid.
Anti-ageing products are formulated by Granvalor to combat signs of ageing at the cellular level by addressing protein breakdown and environmental damage.
Board of directors of Granvalor Pharmaceuticals Private Limited (Granvalor)
Granvalor Pharmaceuticals Private Limited is the primary company behind Granvalor. The board of Granvalor Pharmaceuticals Private Limited currently have 2 directors; the longest-serving is Khaja Aliuddin, appointed in 2011. 1 earlier director has ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Khaja Aliuddin DIN 03447759 | Director | 25 Mar 2011 | 15 yrs 7 mo | Granvalor Pharmaceuticals Private Limited |
| Mohammed Siraj Uddin DIN 03447765 | Director | 25 Mar 2011 | 15 yrs 7 mo | Granvalor Pharmaceuticals Private Limited |
Financials of Granvalor
Figures of Granvalor Pharmaceuticals Private Limited, the primary company behind Granvalor, for FY 2025. Revenue was ₹2.14 Cr (+22% year on year). Net profit was ₹6.7 Lakh (3% margin). EBITDA was ₹10.6 Lakh (5% margin). Revenue has grown at a compounded annual rate of +14% over three years and +9% over five years.
- ₹2.14 CrRevenue · FY 2025 · +22% YoY
- ₹6.7 LakhNet profit · 3% margin
- ₹10.6 LakhEBITDA · 5% margin
- ₹1 LakhPaid-up capital
- 4Employees (provident fund records)
- +14%Revenue CAGR, 3 years
- +9%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Granvalor Pharmaceuticals Private Limited are on its company page.
Detailed financial statements for Granvalor
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Granvalor
Granvalor has 4 employees.
The primary company behind Granvalor, Granvalor Pharmaceuticals Private Limited, reported revenue of ₹2.14 Cr for FY 2025, up 22% year on year.
Granvalor is recognized as a promising speciality dermatology and cosmeceutical company in India, where innovative therapeutic solutions are introduced for cosmetic and clinical dermatology. A commitment is made by the company to provide efficient and reliable products that emphasize high quality and safety profiles. Expertise in skin care is leveraged to develop unique formulations addressing diverse needs of the Indian market, including anti-pigmentation, anti-ageing, hair care, and anti-acne treatments, all while ensuring products meet rigorous standards for efficacy and reliability.
Granvalor offers Anti-Pigmentation Products and Anti-Ageing Products.
Granvalor operates through Granvalor Pharmaceuticals Private Limited.
The legal entities of Granvalor currently have 2 directors, including Khaja Aliuddin, Mohammed Siraj Uddin.